A phase I expansion study of trifluridine and tipiracil (FTD/TPI) in combination with irinotecan (IRI) and bevacizumab (BEV) in patients with metastatic colorectal cancer (mCRC) Meeting Abstract
| Authors: | Varghese, A. M.; Backlund Cardin, D.; Hersch, J.; Bowen Benson, A.; Hochster, H. S.; Winkler, R. E.; Benedetti, F.; Hamada, K.; Berlin, J.; Saltz, L. B. |
| Abstract Title: | A phase I expansion study of trifluridine and tipiracil (FTD/TPI) in combination with irinotecan (IRI) and bevacizumab (BEV) in patients with metastatic colorectal cancer (mCRC) |
| Meeting Title: | 54th Annual Meeting of the American Society of Clinical Oncology (ASCO) |
| Journal Title: | Journal of Clinical Oncology |
| Volume: | 36 |
| Issue: | 15 Suppl. |
| Meeting Dates: | 2018 Jun 1-5 |
| Meeting Location: | Chicago, IL |
| ISSN: | 0732-183X |
| Publisher: | American Society of Clinical Oncology |
| Date Published: | 2018-05-20 |
| Start Page: | 182s |
| Language: | English |
| ACCESSION: | WOS:000442916001513 |
| DOI: | 10.1200/JCO.2018.36.15_suppl.3546 |
| PROVIDER: | wos |
| Notes: | Meeting Abstract: 3546 -- Source: Wos |
Altmetric
Citation Impact
BMJ Impact Analytics
